Literature DB >> 22563905

Real time three-dimensional echocardiographic assessment of left ventricular function in heart failure patients: underestimation of left ventricular volume increases with the degree of dilatation.

Pamela Moceri1, Denis Doyen, David Bertora, Pierre Cerboni, Emile Ferrari, Pierre Gibelin.   

Abstract

BACKGROUND: Accurate quantification of left ventricular (LV) volumes and ejection fraction (EF) is of critical importance. Cardiac magnetic resonance (CMR) is considered as the reference and three-dimensional echocardiography (3DE) is an accurate method, but only few data are available in heart failure patients. We therefore sought to compare the accuracy of real time three-dimensional echocardiography (RT3DE) and two-dimensional echocardiography (2DE) for quantification of LV volumes and EF, relative to CMR imaging in an unselected population of heart failure patients. METHODS AND
RESULTS: We studied 24 patients (17 men, age 58 ± 15 years) with history of heart failure who underwent echocardiographic assessment of LV function (2DE, RT3DE) and CMR within a period of 24 hours. Mean LV end-diastolic volume (LVEDV) was 208 ± 109 mL (121 ± 64 mL/m(2) ) and mean LVEF was 31 ± 12.8%. 3DE data sets correlate well with CMR, particularly with respect to the EF (r: 0.8, 0.86, and 0.95; P < 0.0001 for LVEDV, LVESV, and EF, respectively) with small biases (-55 mL, -44 mL, 1.1%) and acceptable limits of agreement. RT3DE provides more accurate measurements of LVEF than 2DE (z= 2.1, P = 0.037) and lower variability. However, 3DE-derived LV volumes are significantly underestimated in patients with severe LV dilatation. In patients with LVEDV below 120 mL/m(2) , RT3DE is more accurate for volumes and EF evaluation.
CONCLUSION: Compared with CMR, RT3DE is accurate for evaluation of EF and feasible in all our heart failure patients, at the expense of a significant underestimation of LV volumes, particularly when LVEDV is above 120 mL/m(2) .
© 2012, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22563905     DOI: 10.1111/j.1540-8175.2012.01707.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

1.  Prognostic value of real-time three-dimensional echocardiography compared to two-dimensional echocardiography in patients with systolic heart failure.

Authors:  Frederico J N Mancuso; Valdir A Moises; Dirceu R Almeida; Dalva Poyares; Luciana J Storti; Flavio S Brito; Sergio Tufik; Angelo A V de Paola; Antonio C C Carvalho; Orlando Campos
Journal:  Int J Cardiovasc Imaging       Date:  2017-11-02       Impact factor: 2.357

2.  Assessment of LV ejection fraction using real-time 3D echocardiography in daily practice: direct comparison of the volumetric and speckle tracking methodologies to CMR.

Authors:  M M P Driessen; E Kort; M J M Cramer; P A Doevendans; M J Angevaare; T Leiner; F J Meijboom; S A J Chamuleau; G Tj Sieswerda
Journal:  Neth Heart J       Date:  2014-09       Impact factor: 2.380

3.  Assessment of left ventricular ejection fraction in patients eligible for ICD therapy: Discrepancy between cardiac magnetic resonance imaging and 2D echocardiography.

Authors:  S de Haan; K de Boer; J Commandeur; A M Beek; A C van Rossum; C P Allaart
Journal:  Neth Heart J       Date:  2014-10       Impact factor: 2.380

4.  Admittance-based pressure-volume loops versus gold standard cardiac magnetic resonance imaging in a porcine model of myocardial infarction.

Authors:  Gerardus P J van Hout; Sanne J Jansen of Lorkeers; Johannes M I H Gho; Pieter A Doevendans; Wouter W van Solinge; Gerard Pasterkamp; Steven A J Chamuleau; Imo E Hoefer
Journal:  Physiol Rep       Date:  2014-04-22

Review 5.  Echocardiographic assessment of mitral regurgitation: discussion of practical and methodologic aspects of severity quantification to improve diagnostic conclusiveness.

Authors:  Andreas Hagendorff; Fabian Knebel; Andreas Helfen; Stephan Stöbe; Dariush Haghi; Tobias Ruf; Daniel Lavall; Jan Knierim; Ertunc Altiok; Roland Brandt; Nicolas Merke; Sebastian Ewen
Journal:  Clin Res Cardiol       Date:  2021-04-11       Impact factor: 5.460

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.